alexa Current Pharmacologic Otoprotective Agents in or Approaching Clinical Trials: How They Elucidate Mechanisms of Noise-Induced Hearing Loss | OMICS International| Abstract
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Otolaryngology 2013, Vol 3(1): 130
  • DOI: 10.4172/2161-119X.1000130

Current Pharmacologic Otoprotective Agents in or Approaching Clinical Trials: How They Elucidate Mechanisms of Noise-Induced Hearing Loss

Coral Tieu and Kathleen C Campbell*
Southern Illinois University School of Medicine, , Illinois, USA
*Corresponding Author : Kathleen C Campbell, Southern Illinois University School of Medicine, PO Box 19629, Springfield, IL 62794-9629, Illinois, USA, Tel: 217-545-7310, Fax: 217-545-7771, Email: [email protected]

Received Date: Dec 17, 2012 / Accepted Date: Dec 26, 2012 / Published Date: Jan 02, 2013

Abstract

Through understanding the underlying mechanisms of noise-induced hearing loss (NIHL), several promising
pharmacologic otoprotective agents are in development. Conversely, the experimental results with these protective agents further elucidate NIHL mechanisms. This article reviews the major classes of otoprotective agents for NIHL that have undergone published peer reviewed clinical trials, or are currently in or approaching FDA approved clinical trials. Both prophylactic and rescue agents are included. The classes of agents include antioxidants, vasodilators, and glucocorticoids. Apoptotic pathway inhibitors are briefly mentioned. For antioxidants, some of the differences in the exact antioxidant mechanisms are included. Protective agents reviewed include D-methionine, N-acetylcysteine, ebselen, ACE Mg, Acuval, CoQ10, molecular hydrogen, magnesium as a single agent, and dexamethasone. The advantages, disadvantages, and state of development are included for each agent. Both safety and efficacy are considered as are considerations for specific patient populations if known. Further, results of animal and clinical trials are briefly described from the published literature.

Although no pharmacologic agent is yet approved by the FDA for clinical use to prevent or treat noise induced hearing loss at this time, it is hoped that within the next decade and perhaps within the next few years one or more agents will be available for clinical use. Further it is hoped that through an understanding of the underlying mechanisms and noise-induced hearing loss and otoprotection, even more safe and effective pharmacologic otoprotective agents will be developed.

Keywords: N-acetylcysteine, Ebselen, ACE Mg, Acuval, CoQ10, Molecular hydrogen, Magnesium, Dexamethasone

Citation: Tieu C, Campbell KC (2012) Current Pharmacologic Otoprotective Agents in or Approaching Clinical Trials: How They Elucidate Mechanisms of Noise-Induced Hearing Loss. Otolaryngology 3:130. Doi: 10.4172/2161-119X.1000130

Copyright: © 2012 Tieu C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences

Worldwide Forum on Otolaryngology and ENT Surgery

Barcelona, Spain

6th European Otolaryngology-ENT Surgery Conference

Vienna, Austria
Article Usage
  • Total views: 15449
  • [From(publication date): 5-2013 - Aug 08, 2020]
  • Breakdown by view type
  • HTML page views: 11515
  • PDF downloads: 3934
Top